慢性阻塞性肺疾患稳定期舒利迭治疗的临床观察

Clinical Observation of Seretide in Treatment of Chronic Obstructive Pulmonary Disease in Stabilization

目的:探讨慢性阻塞性肺疾患(COPD)稳定期应用舒利迭治疗的临床疗效。方法:随机将COPD稳定期96例患者分为观察组、对照组各48例。两组均给予异丙托溴铵、氨茶碱等常规治疗。观察组在该治疗基础上加用舒利迭治疗。结果:治疗3个月后,观察组治疗前后FEV、FEV1/FVC%及FEV1%预计值均有显著改善(P<0.05);对照组治疗前后各肺功能指标改善不明显。治疗后观察组FEV、FEV1/FVC%及FEV1%预计值改善优于对照组(P<0.05)。治疗期间两组患者均无严重不良反应。结论:将舒利迭用于COPD稳定期治疗,患者肺功能显著改善,不良反应轻微,值得临床应用。

Objective： To explore the clinical effect of seretide in treatment of chronic obstructive pulmonary disease in stabilization. Method：96 cases were divided into two groups,the observation group（n=48） and the control group（n=46）.All cases were given the routine treatment including ipratmpium and aminophylline.The observation group were given by Seretide in addition. Result： The differences in FEV1,FEV1/FVC×100%and FEV1%were significant in the observation group before and after therapy（P0.05）.And they were significant in the control group before and after therapy（P0.05）.During the treatment period there＇s no adverse reaction in two groups. Conclusion： Seretide can elevate the pulmonary function,with less adverse reaction,It＇s worthy of clinical apply.